GGrantIndex
Sort

11,323 grants matching glioblastoma

Systematic Development of Novel, Druggable Cancer Targets

$788,540
Michael E. Berens · Translational Genomics Research Inst · U01 · FY2014 · CA

Signal transduction in development and disease

$788,378
Rajat Rohatgi · Stanford University · R35 · FY2021 · GM

Angiogenesis imaging

$787,458
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Image-based models of tumor-immune dynamics in glioblastoma

$785,579
Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2021 · CA

Improved Whole-Brain Spectroscopic MRI for Radiation Treatment Planning

$784,397
Hyunsuk Shim · Emory University · U01 · FY2019 · EB

Transport Processes and Nervous System Function

$783,635
Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD

Systematic Development of Novel, Druggable Cancer Targets

$783,005
Michael E. Berens · Translational Genomics Research Inst · U01 · FY2013 · CA

Transport Processes and Nervous System Function

$782,224
Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD

Vaccines and Therapeutics for Anthrax

$781,786
Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Transport Processes and Nervous System Function

$779,395
Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD

Project 1: Analysis of cell autonomous mechanisms of phenotypic switching in invasive cancer models

$778,732
Andre Levchenko · Yale University · U54 · FY2018 · CA

A Phase I Study of EGFRvIII Peptide Vaccination (CDX-110) after Conventional Radi

$777,986
Paul Graham Fisher · Stanford University · RC2 · FY2009 · CA

Personalized Neural Stem Cell Therapy for Cancer

$776,434
Susan Nichols · Falcon Therapeutics, Inc. · R42 · FY2020 · TR

Immobilized Receptors In Drug Discovery

$776,063
Irving William Wainer · National Institute On Aging · ZIA · FY2013 · AG

Microenvironmental regulation of glioblastoma radiosensitivity

$775,280
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Improved Whole-Brain Spectroscopic MRI for Radiation Treatment Planning

$775,037
Hyunsuk Shim · Emory University · U01 · FY2020 · EB

The Laboratory of Stem Cell Biology

$772,987
Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR

Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma

$772,615
John H Sampson · Annias Immunotherapeutics, Inc. · R42 · FY2017 · CA

TUNE AND STRIKE TARGETING OF GLIOBLASTOMA

$771,627
The General Hospital Corporation · · FY2025 · Defense Health Agency

Personal tumor neoantigens for immunity against chronic lymphocytic leukemia

$771,133
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma

$770,432
Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA

Mouse Models for Human Cancer

$770,255
Raju S Kucherlapati · Brigham And Women'S Hospital · U01 · FY2012 · CA

A Phase I Study of EGFRvIII Peptide Vaccination (CDX-110) after Conventional Radi

$770,133
Paul Graham Fisher · Stanford University · RC2 · FY2010 · CA

Molecular Profiling of Patients Undergoing Radiotherapy

$769,009
Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$768,706
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA